Bering Capital

12/24/2021

Incredibly long journey, and the COVID-19 pill created by Dr. George Painter, Bering Capital's advisor is finally authorized by the FDA!

Many adults at high risk of severe disease could take the easy-to-use therapy to avoid hospitalization. It was found to be less effective than a just-approved drug by Pfizer in reducing the risk of hospitalization and death.

12/24/2021

The WSJ story of Molnupiravir, the COVID-19 drug created by Bering Capital advisor Dr. George Painter

A drug’s nearly two-year journey from a university lab, sped by a partnership with drug giant Merck, is the latest example of the unlikely sources of pandemic antidotes.

10/01/2021

https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-covid-19-pill-cuts-risk-death-hospitalization-by-50-study-2021-10-01/
Dr. George Painter (Emory University) is Bering Capital advisor and the inventor of Molnupiravir. This is a better than expected outcome and a real breakthrough in our quest to protect the humankind from the pandemic (and future pandemics).

A pill developed by U.S. drugmaker Merck could half the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, with experts hailing it as a potential breakthrough in how the virus is treated.

06/05/2021

https://calcimedica.com/2021/06/02/calcimedica-publishes-positive-data-from-phase-2a-study-of-auxora-in-patients-with-acute-pancreatitis-and-announces-first-patients-dosed-in-phase-2b-study/

05/30/2021

https://www.nytimes.com/2021/05/22/opinion/drug-developed-covid-19-pill.html?referringSource=articleShare
Excellent review of the new approach to antiviral drug discovery and development created by Altesa BioSciences founding team

The Big Pharma drug model is inefficient and unsustainable. There is an alternative.

02/15/2021

https://expert.ru/expert/2021/08/ya-i-ne-ukhodil-iz-nauki-sovsem/

На вложениях в биотехнологические стартапы сибиряк Евгений Зайцев, начинавший свою карьеру как ученый, зарабатывает больше, чем вся РВК. В чем секрет успеха?